Healthcare-Associated COVID-19 across Five Pandemic Waves: Prediction Models and Genomic Analyses.
genomic analysis
healthcare-associated COVID-19
prediction modelling
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
18 10 2022
18 10 2022
Historique:
received:
29
07
2022
revised:
30
09
2022
accepted:
17
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
Healthcare-associated SARS-CoV-2 infections need to be explored further. Our study is an analysis of hospital-acquired infections (HAIs) and ambulatory healthcare workers (aHCWs) with SARS-CoV-2 across the pandemic in a Belgian university hospital. We compared HAIs with community-associated infections (CAIs) to identify the factors associated with having an HAI. We then performed a genomic cluster analysis of HAIs and aHCWs. We used this alongside the European Centre for Disease Control (ECDC) case source classifications of an HAI. Between March 2020 and March 2022, 269 patients had an HAI. A lower BMI, a worse frailty index, lower C-reactive protein (CRP), and a higher thrombocyte count as well as death and length of stay were significantly associated with having an HAI. Using those variables to predict HAIs versus CAIs, we obtained a positive predictive value (PPV) of 83.6% and a negative predictive value (NPV) of 82.2%; the area under the ROC was 0.89. Genomic cluster analyses and representations on epicurves and minimal spanning trees delivered further insights into HAI dynamics across different pandemic waves. The genomic data were also compared with the clinical ECDC definitions for HAIs; we found that 90.0% of the 'definite', 87.8% of the 'probable', and 70.3% of the 'indeterminate' HAIs belonged to one of the twenty-two COVID-19 genomic clusters we identified. We propose a novel prediction model for HAIs. In addition, we show that the management of nosocomial outbreaks will benefit from genome sequencing analyses.
Sections du résumé
BACKGROUND
Healthcare-associated SARS-CoV-2 infections need to be explored further. Our study is an analysis of hospital-acquired infections (HAIs) and ambulatory healthcare workers (aHCWs) with SARS-CoV-2 across the pandemic in a Belgian university hospital.
METHODS
We compared HAIs with community-associated infections (CAIs) to identify the factors associated with having an HAI. We then performed a genomic cluster analysis of HAIs and aHCWs. We used this alongside the European Centre for Disease Control (ECDC) case source classifications of an HAI.
RESULTS
Between March 2020 and March 2022, 269 patients had an HAI. A lower BMI, a worse frailty index, lower C-reactive protein (CRP), and a higher thrombocyte count as well as death and length of stay were significantly associated with having an HAI. Using those variables to predict HAIs versus CAIs, we obtained a positive predictive value (PPV) of 83.6% and a negative predictive value (NPV) of 82.2%; the area under the ROC was 0.89. Genomic cluster analyses and representations on epicurves and minimal spanning trees delivered further insights into HAI dynamics across different pandemic waves. The genomic data were also compared with the clinical ECDC definitions for HAIs; we found that 90.0% of the 'definite', 87.8% of the 'probable', and 70.3% of the 'indeterminate' HAIs belonged to one of the twenty-two COVID-19 genomic clusters we identified.
CONCLUSIONS
We propose a novel prediction model for HAIs. In addition, we show that the management of nosocomial outbreaks will benefit from genome sequencing analyses.
Identifiants
pubmed: 36298847
pii: v14102292
doi: 10.3390/v14102292
pmc: PMC9607632
pii:
doi:
Substances chimiques
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Int J Environ Res Public Health. 2021 Jan 09;18(2):
pubmed: 33435324
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Biochem Biophys Res Commun. 2022 Jan 29;590:34-41
pubmed: 34968782
Nature. 2021 Aug;596(7871):276-280
pubmed: 34237773
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Lancet Infect Dis. 2022 Feb;22(2):183-195
pubmed: 34756186
Elife. 2020 May 11;9:
pubmed: 32392129
J Hosp Infect. 2020 Dec;106(4):663-672
pubmed: 33065193
Int J Lab Hematol. 2020 Dec;42(6):e252-e255
pubmed: 32915507
Lancet Infect Dis. 2021 Sep;21(9):1246-1256
pubmed: 33857406
Lancet Infect Dis. 2020 Nov;20(11):1263-1272
pubmed: 32679081
J Hosp Infect. 2021 Apr;110:178-183
pubmed: 33571558
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512